(Q54040780)

24 May 2018

title

Prognostic value of c-erbB2 and other markers in patients treated with chemotherapy for recurrent head and neck cancer. (English)

1 reference

24 May 2018

1 reference

1

1 reference

24 May 2018

author name string

Rasmussen AA

2

1 reference

24 May 2018

Johnston PG

3

1 reference

24 May 2018

Langmacher M

4

1 reference

24 May 2018

Baylor A

5

1 reference

24 May 2018

Lee M

6

1 reference

24 May 2018

Cullen KJ

7

1 reference

24 May 2018

publication date

1 September 2000

1 reference

24 May 2018

published in

Head & Neck

1 reference

24 May 2018

volume

22

1 reference

24 May 2018

issue

6

1 reference

24 May 2018

page(s)

599-608

1 reference

24 May 2018

Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0347%28200009%2922%3A6%3C599%3A%3AAID-HED9%3E3.0.CO%3B2-M

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0347%28200009%2922%3A6%3C599%3A%3AAID-HED9%3E3.0.CO%3B2-M

Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0347%28200009%2922%3A6%3C599%3A%3AAID-HED9%3E3.0.CO%3B2-M

HER-2/neu Oncogene Characterization in Head and Neck Squamous Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0347%28200009%2922%3A6%3C599%3A%3AAID-HED9%3E3.0.CO%3B2-M

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0347%28200009%2922%3A6%3C599%3A%3AAID-HED9%3E3.0.CO%3B2-M

Relationship of glutathione and glutathione-S-transferase to cisplatin sensitivity in human head and neck squamous carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0347%28200009%2922%3A6%3C599%3A%3AAID-HED9%3E3.0.CO%3B2-M

Glutathione content but not gamma glutamyl cysteine synthetase mRNA expression predicts cisplatin resistance in head and neck cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0347%28200009%2922%3A6%3C599%3A%3AAID-HED9%3E3.0.CO%3B2-M

Multidrug resistance mediated by the multidrug resistance protein (MRP) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0347%28200009%2922%3A6%3C599%3A%3AAID-HED9%3E3.0.CO%3B2-M

Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0347%28200009%2922%3A6%3C599%3A%3AAID-HED9%3E3.0.CO%3B2-M

New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0347%28200009%2922%3A6%3C599%3A%3AAID-HED9%3E3.0.CO%3B2-M

DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0347%28200009%2922%3A6%3C599%3A%3AAID-HED9%3E3.0.CO%3B2-M

p53 mutation as a prognostic marker in advanced laryngeal carcinoma. Department of Veterans Affairs Laryngeal Cancer Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0347%28200009%2922%3A6%3C599%3A%3AAID-HED9%3E3.0.CO%3B2-M

The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0347%28200009%2922%3A6%3C599%3A%3AAID-HED9%3E3.0.CO%3B2-M

10.1002/1097-0347(200009)22:6<599::AID-HED9>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018